Stay informed with the latest updates for the inheritable blood disorders community. IndustryCSL's FXIII Product Approved for Expanded UseApr 1, 2013 IndustryBiogen Reports A-LONG and B-LONG Studies ProgressMar 1, 2013 IndustryGilead's HCV Therapy Trials On TrackMar 1, 2013 IndustryIdenix Ceases Development of Two HCV DrugsMar 1, 2013 IndustryCangene to Acquire IB1001 from InspirationMar 1, 2013 IndustryGreen Cross Initiates Phase III Trial of rFVIII ProductFeb 1, 2013 IndustryBaxter Announces Inhibitor Study Results, Acquisition of Inspiration…Feb 1, 2013 IndustryBiogen Idec Submits FDA Application for Long-Acting FIX TherapyFeb 1, 2013 IndustryCSL Behring Enrolls Pediatric Patient in Hemophilia B StudyFeb 1, 2013 IndustryBaxter Presents Data on Developmental Recombinant FIX ProductJan 1, 2013 IndustryNovo Nordisk Seeks Regulatory Approval for Recombinant FVIII DrugNov 1, 2012 IndustryAbbott Announces Success in HCV Triple Drug Combo TrialNov 1, 2012 IndustryFDA Rescinds Exclusivity for Octapharma's WilateSep 1, 2012 IndustryInspiration Announces Global Agreement with IpsenSep 1, 2012 IndustrySetbacks for Hepatitis C Drugs in Clinical TrialsSep 1, 2012 Pagination First page Previous page … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 … Next page Last page
